Article
Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival.
PloS one - 1 Jan 2017
Sausville Lindsay N, Jones Carissa C, Aldrich Melinda C, Blot William J, Pozzi Ambra, Williams Scott M
Abstract excerpt
Globally, lung cancer results in more deaths worldwide than any other cancer, indicating a need for better treatments. Members of the eicosanoid metabolism pathway represent promising therapeutic targets, as several enzymes involved in the generation of these lipids are dysregulated in many cancers and their inhibition reduces lung cancer growth in mouse models. However, genetic variation of enzymes involved in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
